LTFS
ATXS

Ladenburg Thalmann Financial Services’s Astria Therapeutics ATXS Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Sell
21
-72
-77% -$2.27K ﹤0.01% 5036
2019
Q3 		$3K Buy
+93
New +$3.68K ﹤0.01% 4830

Other funds holding ATXS

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ATXS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Astria Therapeutics (ATXS) stake by 77% in Q4 2019, selling an estimated $2.27K and leaving 21 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5036.

Ladenburg Thalmann Financial Services first reported a position in ATXS in Q3 2019 and has held it in 2 quarters since. The position peaked at $3K in Q3 2019. 28 funds tracked by Wall St. Rank hold ATXS as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 21 shares of Astria Therapeutics worth $2K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 72 Astria Therapeutics shares in Q4 2019, an estimated $2.27K.
  • Astria Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5036 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Astria Therapeutics in Q3 2019 and has held it in 2 quarters since.
  • Ladenburg Thalmann Financial Services's Astria Therapeutics position peaked at $3K in Q3 2019.
  • 28 funds tracked by Wall St. Rank held Astria Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.